Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from (223)Ra-dichloride to new horizons for therapeutic response assessment

Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):5-7. doi: 10.1007/s00259-015-3189-0. Epub 2015 Sep 18.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Male
  • Nuclear Medicine / trends*
  • Prostatic Neoplasms, Castration-Resistant / radiotherapy*
  • Radium / therapeutic use*
  • Treatment Outcome

Substances

  • Radium